DAC Patient Recruitment Debuts Updated DACTracks Clinical Trial Metrics Software
As a clinical trial sponsor, being able to measure research programs with pinpoint accuracy is a valuable proposition.
As a clinical trial sponsor, being able to measure research programs with pinpoint accuracy is a valuable proposition. That's precisely what DAC Patient Recruitment Services (DAC), an Imperial company and a leader in clinical trial patient recruitment and retention, offers through its proprietary DACTracks™ technology.
"Evaluating real-time program data is essential in analyzing return on investment," said DAC Vice President of Operations Melynda Geurts. "That is why DAC created DACTracks. This active, online reporting system keeps valuable program data at our clients' fingertips."
Sponsors will enjoy 24-hour access to reports on their research sites' screenings, referrals, randomizations (projected and actual), enrollment, attrition, and more. Both site-specific and global data are available. Impact graphs map recruitment trends following the launch of specific initiatives, and charts display the number of aggregate and site-specific referrals color-coded by source. The retention page features the total number of active and non-active subjects in the study and a summary of discontinued subjects, including reasons for discontinuation.
DACTracks also provides comprehensive statistics on study website performance, including unique site visitors, page views, online pre-qualification, and web traffic sources. Regarding the latter, users will be able to discern at the click of a mouse whether web traffic originated from search engines, referring sites or direct traffic to the study website URL.
For more information about DACTracks, and to sign up for a free demonstration, visit www.imperialcrs.com/dac/dactracks or write to [email protected]
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
